Bcl-2 promotes premature senescence induced by oncogenic Ras

Biochemical and Biophysical Research Communications

Volumn 303, Issue 3, 2003, Pages 800-807

  Tombor, Bálint ^a   Rundell, Kathleen ^a   Oltvai, Zoltán N ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Apoptosis; Bcl 2; Cell cycle; Oncogene; Ras; Senescence; Tumorigenesis

Indexed keywords

HYDROGEN PEROXIDE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE; SIGNAL TRANSDUCTION;

EID: 0344643404     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00402-9     Document Type: Article

References (35)

1. Hayflick L., Moorhead P.S. The serial cultivation of human diploid fibroblast cell strains. Exp. Cell Res. 25:1961;585-621.
2. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
3. Chen Q., Ames B.N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. USA. 91:1994;4130-4134.
4. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
5. Sherr C.J., DePinho R.A. Cellular senescence: mitotic clock or culture shock? Cell. 102:2000;407-410.
6. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., Lowe S.W. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 109:2002;335-346.
7. Adams J.M., Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26:2001;61-66.
8. Martinou J.C., Green D.R. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell. Biol. 2:2001;63-67.
9. Marvel J., Perkins G.R., Lopez Rivas A., Collins M.K. Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation. Oncogene. 9:1994;1117-1122.
10. Linette G.P., Li Y., Roth K., Korsmeyer S.J. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. USA. 93:1996;9545-9552.
11. Brady H.J., Gil-Gomez G., Kirberg J., Berns A.J. Bax α perturbs T cell development and affects cell cycle entry of T cells. EMBO J. 15:1996;6991-7001.
12. Fairbairn L.J., Cowling G.J., Reipert B.M., Dexter T.M. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell. 74:1993;823-832.
13. Sato N., Hotta K., Waguri S., Nitatori T., Tohyama K., Tsujimoto Y., Uchiyama Y. Neuronal differentiation of PC12 cells as a result of prevention of cell death by bcl-2. J. Neurobiol. 25:1994;1227-1234.
14. Lu P.J., Lu Q.L., Rughetti A., Taylor-Papadimitriou J. bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J. Cell Biol. 129:1995;1363-1378.
15. Uhlmann E.J., D'Sa-Eipper C., Subramanian T., Wagner A.J., Hay N., Chinnadurai G. Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res. 56:1996;2506-2509.
16. Huang D.C., O'Reilly L.A., Strasser A., Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16:1997;4628-4638.
17. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to supress bcl-2 is involved. Cancer Res. 55:1995;2284-2292.
18. Bladier C., Wolvetang E.J., Hutchinson P., de Haan J.B., Kola I. Response of a primary human fibroblast cell line to H2O2: senescence-like growth arrest or apoptosis? Cell Growth Differ. 8:1997;589-598.
19. Chen Q.M., Liu J., Merrett J.B. Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem. J. 347:2000;543-551.
20. Bruckheimer E.M., Brisbay S., Johnson D.J., Gingrich J.R., Greenberg N., McDonnell T.J. Bcl-2 accelerates multistep prostate carcinogenesis in vivo. Oncogene. 19:2000;5251-5258.
21. Morgenstern J.P., Land H. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res. 18:1990;1068.
22. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
23. Morales C.P., Holt S.E., Ouellette M., Kaur K.J., Yan Y., Wilson K.S., White M.A., Wright W.E., Shay J.W. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21:1999;115-118.
24. Yu J., Boyapati A., Rundell K. Critical role for SV40-small t antigen in human cell transformation. Virology. 290:2001;192-198.
25. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O.et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad Sci. USA. 92:1995;9363-9367.
26. Pollice A.A., McCoy J.P. Jr., Shackney S.E., Smith C.A., Agarwal J., Burholt D.R., Janocko L.E., Hornicek F.J., Singh S.G., Hartsock R.J. Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry. 13:1992;432-444.
27. Wang J., Xie L.Y., Allan S., Beach D., Hannon G.J. Myc activates telomerase. Genes Dev. 12:1998;1769-1774.
28. Duelli D.M., Lazebnik Y.A. Primary cells suppress oncogene-dependent apoptosis. Nat. Cell Biol. 2:2000;859-862.
29. Rincheval V., Renaud F., Lemaire C., Godefroy N., Trotot P., Boulo V., Mignotte B., Vayssiere J.L. Bcl-2 can promote p53-dependent senescence versus apoptosis without affecting the G1/S transition. Biochem. Biophys. Res. Commun. 298:2002;282-288.
30. Ling Y.H., Tornos C., Perez-Soler R. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J. Biol. Chem. 273:1998;18984-18991.
31. Poommipanit P.B., Chen B., Oltvai Z.N. Interleukin-3 induces the phosphorylation of a distinct fraction of bcl-2. J. Biol. Chem. 274:1999;1033-1039.
32. Lind E.F., Wayne J., Wang Q.Z., Staeva T., Stolzer A., Petrie H.T. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions. J. Immunol. 162:1999;5374-5379.
33. Vairo G., Soos T.J., Upton T.M., Zalvide J., DeCaprio J.A., Ewen M.E., Koff A., Adams J.M. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Mol. Cell. Biol. 20:2000;4745-4753.
34. Pezzella F., Turley H., Kuzu I., Tungekar M.F., Dunnill M.S., Pierce C.B., Harris A., Gatter K.C., Mason D.Y. Bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med. 329:1993;690-694.
35. Athanassiadou P., Dosios T., Petrakakou E., Liossi A., Zerva C., Athanassiades P. p53 and bcl-2 protein expression in non-small-cell lung carcinoma. Diagn. Cytopathol. 19:1998;255-259.